Search results
Results from the WOW.Com Content Network
As of 2016, the EMA was roughly parallel to the drug part of the U.S. Food and Drug Administration (FDA), [53] but without centralisation. [54] The timetable for product approval via the EMA's centralised procedure of 210 days compares well with the average of 500 days taken by the FDA in 2008 to evaluate a product. [55]
As part of the deal, the country agreed to cut its budget deficit from 9.8 percent of GDP in 2010 to 5.9 percent in 2011, 4.5 percent in 2012 and 3 percent in 2013. [10] In June 2011, Portugal officially requested the €78 billion IMF-EU bailout package in a bid to stabilise its public finances. [11]
State Agency of Medicines Zāļu valsts aģentūra (ZVA) 2004 Liechtenstein: Office of Healthcare Amt für Gesundheit (AG) 1995 Lithuania: State Medicines Control Agency (SMCA) 2009 Malaysia: National Pharmaceutical Regulatory Agency (NPRA) Bahagian Regulatori Farmasi Negara: 2002 Malta: Malta Medicines Authority (MMA) 2008 Mexico
This article is part of a series on: Politics of the European Union. Member states (27) ... Portugal Romania Slovakia ...
Swayed by the low cost of living, a supportive health care system, wonderful weather and excellent tax incentives, Portugal has long been a destination for retirees the world over. Add in the...
(mentioned as part of stage 2 in the updated 2015 reform plan) Establish an increasing degree of "common decision-making on national budgets" and an "enhanced coordination of economic policies" . A subject to "enhanced coordination", could in example be the specific taxation and employment policies implemented by the National Job Plan of each ...
Citing what it calls a potentially “dire situation,” State Farm on Monday asked California for permission to hike insurance rates by an average of 22%. In the wake of the Los Angeles-area ...
Marketing Authorisation Application (MAA) is an application submitted by a drug manufacturer seeking marketing authorisation, that is permission to bring a medicinal product (for example, a new medicine or generic medicine) to the market.